| Literature DB >> 35530670 |
Haolin Xin1, Ying Cui2, Zhongping An1, Qian Yang1, Xuan Zou1, Ning Yu1.
Abstract
Glutamate is an excitatory neurotransmitter involved in neural function. Excess accumulation of intercellular glutamate leads to increasing concentration of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in neuronal cells. In this study, we investigated the antioxidant activity of several typical superior compounds among four neuronal cells, and determined the scavenging activity of free radicals. The in vivo assay was also carried out to compare the protective effect of glutamate-induced cell damage. Hierarchical clustering analysis was used to identify the common properties. Glutamate induced neurotoxicity and ROS production, suggesting glutamate cytotoxicity was related to oxidative stress and widely exists in different cell lines. Those screening compounds exhibited strong antioxidant ability, but low cytotoxicity to neuronal cells, acting as agents against neurodegenerative diseases. Finally, a hierarchical clustering analysis assay indicated that hyperoside and rutin hydrate are the most effective compounds for attenuating intercellular ROS levels. The results suggested the activity more or less relies on structure, rather than residues. These data generate new supporting ideas to remove intracellular ROS and the identified compounds serve as potential therapeutic agents in multiple neurological diseases. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35530670 PMCID: PMC9074000 DOI: 10.1039/c9ra03848e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 3Radical scavenging activity of antioxidant compounds. (A) Chemical structure of selected compounds. (B) IC50 of ABTS and DPPH assay. (C) Cell viability assay at 64 μg ml−1 compound in various cells. Relative (D) peroxyl radical and (E) hydroxyl radical assay. (F) NO scavenging activity assay.
Fig. 1Glutamate-induced neural cell viability. (A) PC22, (B) SH-SY5Y, (C) HT-22 and (D) primary astrocytes cell viability by CCK-8 assay.
Fig. 2(A) Glutamate-induced ROS production in neural cells, using ROS-sensitive fluorometric probe DCFDA by flow cytometry (n = 10 000 cells). (B) Relative ROS production in all tested cells.
ABTS scavenging activity at different concentrationsa
| Concentration μg ml−1 | Caffeic acid | Quercetin | Gallic acid | Kaempferol | Catechin | Hyperoside | Rutin hydrate |
|---|---|---|---|---|---|---|---|
| 1 | 39.8 ± 1.7 | 35.8 ± 4.3 | 48.8 ± 4.7 | 33.4 ± 5.2 | 27.8 ± 1.3 | 43.1 ± 4.2 | 23.5 ± 8.5 |
| 4 | 71.4 ± 5.1 | 70.4 ± 5.3 | 80.4 ± 5.3 | 47.5 ± 6.5 | 64.4 ± 3.1 | 58.1 ± 5.2 | 37.1 ± 2.4 |
| 16 | 88.3 ± 6.9 | 85.9 ± 6.4 | 95.9 ± 2.4 | 63.2 ± 3.7 | 78.8 ± 2.9 | 68.2 ± 2.5 | 74.5 ± 4.6 |
| 64 | 95.2 ± 5.6 | 94.2 ± 4.2 | 99.2 ± 1.2 | 83.3 ± 4.1 | 92.8 ± 5.5 | 83.5 ± 2.6 | 88.2 ± 3.4 |
Data are expressed as mean ± SD of n = 6.
DPPH scavenging activity at different concentrationsa
| Concentration μg ml−1 | Caffeic acid | Quercetin | Gallic acid | Kaempferol | Catechin | Hyperoside | Rutin hydrate |
|---|---|---|---|---|---|---|---|
| 1 | 29.2 ± 5.7 | 38.8 ± 7.8 | 44.3 ± 5.7 | 30.4 ± 7.1 | 29.8 ± 7.3 | 42.1 ± 5.5 | 28.5 ± 5.5 |
| 4 | 51.2 ± 5.4 | 75.4 ± 3.2 | 75.4 ± 4.3 | 42.1 ± 2.5 | 45.4 ± 8.7 | 56.1 ± 6.2 | 36.1 ± 4.4 |
| 16 | 73.3 ± 2.3 | 86.9 ± 6.3 | 93.5 ± 3.4 | 61.2 ± 3.7 | 72.8 ± 5.9 | 68.2 ± 6.6 | 78.5 ± 4.7 |
| 64 | 85.4 ± 5.3 | 96.2 ± 4.1 | 98.2 ± 0.2 | 80.3 ± 4.4 | 85.5 ± 8.3 | 86.5 ± 6.3 | 89.2 ± 4.4 |
Data are expressed as mean ± SD of n = 6.
Fig. 4Attenuated glutamate-induced ROS production of (A) PC22, (B) SH-SY5Y, (C) HT-22 and (D) primary astrocytes ROS production by flow cytometry. (E) Hierarchical clustering analysis of ROS production.